Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients.

Purpose: To estimate the economic impact of a Tegaderm chlorhexidine gluconate (CHG) gel dressing compared with a standard intravenous (i.v.) dressing (defined as non-antimicrobial transparent film dressing), used for insertion site care of short-term central venous and arterial catheters (intravascular catheters) in adult critical care patients using a cost-consequence model populated with data from published sources.